Desai Karishma, Carroll Ian, Asch Steven M, Seto Tina, McDonald Kathryn M, Curtin Catherine, Hernandez-Boussard Tina
Department of Medicine, Stanford University, Stanford, California.
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California.
J Surg Res. 2018 Aug;228:160-169. doi: 10.1016/j.jss.2018.03.029. Epub 2018 Apr 11.
Although evidence-based guidelines recommend a multimodal approach to pain management, limited information exists on adherence to these guidelines and its association with outcomes in a generalized population. We sought to assess the association between discharge multimodal analgesia and postoperative pain outcomes in two diverse health care settings.
We evaluated patients undergoing four common surgeries associated with high pain in electronic health records from an academic hospital (AH) and Veterans Health Administration (VHA). Multimodal analgesia at discharge was characterized as opioids in combination with acetaminophen (O + A) and nonsteroidal antiinflammatory (O + A + N) drugs. Hierarchical models estimated associations of analgesia with 45-d follow-up pain scores and 30-d readmissions.
We identified 7893 patients at AH and 34,581 at VHA. In both settings, most patients were discharged with O + A (60.6% and 54.8%, respectively), yet a significant proportion received opioids alone (AH: 24.3% and VHA: 18.8%). Combining acetaminophen with opioids was associated with decreased follow-up pain in VHA (Odds ratio [OR]: 0.86, 95% confidence interval [CI]: 0.79, 0.93) and readmissions (AH OR: 0.74, CI: 0.60, 0.90; VHA OR: 0.89, CI: 0.82, 0.96). Further addition of nonsteroidal antiinflammatory drugs was associated with further decreased follow-up pain (AH OR: 0.71, CI: 0.53, 0.96; VHA OR: 0.77, CI: 0.69, 0.86) and readmissions (AH OR: 0.46, CI: 0.31, 0.69; VHA OR: 0.84, CI: 0.76, 0.93). In both systems, patients receiving multimodal analgesia received 10%-40% less opioids per day compared to opioids only.
A majority of surgical patients receive a multimodal pain approach at discharge yet many receive only opioids. Multimodal regimen at discharge was associated with better follow-up pain and all-cause readmissions compared to the opioid-only regimen.
尽管循证指南推荐采用多模式方法进行疼痛管理,但关于这些指南的依从性及其与普通人群预后的关联,相关信息有限。我们旨在评估在两种不同的医疗环境中,出院时多模式镇痛与术后疼痛结局之间的关联。
我们在一家学术医院(AH)和退伍军人健康管理局(VHA)的电子健康记录中,评估了接受四种与高疼痛相关的常见手术的患者。出院时的多模式镇痛被定义为阿片类药物与对乙酰氨基酚(O + A)以及非甾体抗炎药(O + A + N)联合使用。分层模型估计了镇痛与45天随访疼痛评分以及30天再入院之间的关联。
我们在AH识别出7893例患者,在VHA识别出34581例患者。在这两种环境中,大多数患者出院时使用O + A(分别为60.6%和54.8%),但仍有相当比例的患者仅接受阿片类药物(AH:24.3%,VHA:18.8%)。在VHA,对乙酰氨基酚与阿片类药物联合使用与随访疼痛减轻相关(优势比[OR]:0.86,95%置信区间[CI]:0.79,0.93)以及再入院率降低相关(AH的OR:0.74,CI:0.60,0.90;VHA的OR:0.89,CI:0.82,0.96)。进一步添加非甾体抗炎药与随访疼痛进一步减轻相关(AH的OR:0.71,CI:0.53,0.96;VHA的OR:0.77,CI:0.69,0.86)以及再入院率降低相关(AH的OR:0.46,CI:0.31,0.69;VHA的OR:0.84,CI:0.76,0.93)。在这两个系统中,接受多模式镇痛的患者每天使用的阿片类药物比仅使用阿片类药物的患者少10% - 40%。
大多数手术患者出院时接受多模式疼痛管理方法,但许多患者仅接受阿片类药物。与仅使用阿片类药物的方案相比,出院时的多模式方案与更好的随访疼痛和全因再入院率相关。